1. Home
  2. SOC vs IMVT Comparison

SOC vs IMVT Comparison

Compare SOC & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOC
  • IMVT
  • Stock Information
  • Founded
  • SOC 2020
  • IMVT N/A
  • Country
  • SOC United States
  • IMVT United States
  • Employees
  • SOC N/A
  • IMVT N/A
  • Industry
  • SOC
  • IMVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SOC
  • IMVT Health Care
  • Exchange
  • SOC Nasdaq
  • IMVT Nasdaq
  • Market Cap
  • SOC 3.0B
  • IMVT 2.5B
  • IPO Year
  • SOC N/A
  • IMVT N/A
  • Fundamental
  • Price
  • SOC $28.79
  • IMVT $14.85
  • Analyst Decision
  • SOC Buy
  • IMVT Buy
  • Analyst Count
  • SOC 4
  • IMVT 10
  • Target Price
  • SOC $30.50
  • IMVT $40.14
  • AVG Volume (30 Days)
  • SOC 3.2M
  • IMVT 1.2M
  • Earning Date
  • SOC 05-09-2025
  • IMVT 05-29-2025
  • Dividend Yield
  • SOC N/A
  • IMVT N/A
  • EPS Growth
  • SOC N/A
  • IMVT N/A
  • EPS
  • SOC N/A
  • IMVT N/A
  • Revenue
  • SOC N/A
  • IMVT N/A
  • Revenue This Year
  • SOC N/A
  • IMVT $108.88
  • Revenue Next Year
  • SOC N/A
  • IMVT N/A
  • P/E Ratio
  • SOC N/A
  • IMVT N/A
  • Revenue Growth
  • SOC N/A
  • IMVT N/A
  • 52 Week Low
  • SOC $13.66
  • IMVT $12.72
  • 52 Week High
  • SOC $35.00
  • IMVT $34.47
  • Technical
  • Relative Strength Index (RSI)
  • SOC 56.49
  • IMVT 50.48
  • Support Level
  • SOC $26.66
  • IMVT $13.79
  • Resistance Level
  • SOC $33.29
  • IMVT $15.22
  • Average True Range (ATR)
  • SOC 2.08
  • IMVT 0.69
  • MACD
  • SOC -0.17
  • IMVT 0.13
  • Stochastic Oscillator
  • SOC 34.85
  • IMVT 78.24

About SOC Sable Offshore Corp. Common Stock

Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California. The company is managed as one reportable segment, oil and gas.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).

Share on Social Networks: